Biotech startup Neuraly, a Johns Hopkins spinout, raises $36M to develop disease-modifying treatment for Parkinson’s disease
According to Parkinson’s Foundation, about one million Americans live with Parkinson’s disease (PD), which is more than the combined number of people diagnosed with multiple sclerosis, muscular dystrophy and Lou Gehrig’s disease (or Amyotrophic Lateral Sclerosis). Every year, approximately 60,000 […]